Alyeska Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

Alyeska Investment Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-447,200	Closed	-$67.7M	–	775
2020 Q4	$67.7M	Buy	447,200 +287,200	+180%	+$41M	0.96%	13
2020 Q3	$21.7M	Buy	160,000 +107,600	+205%	+$14.6M	0.33%	94
2020 Q2	$7.16M	Buy	52,400 +13,000	+33%	+$1.66M	0.11%	227
2020 Q1	$4.25M	Buy	+39,400	New	+$4.54M	0.08%	205
2019 Q4	–	Sell	-100,000	Closed	-$9.95M	–	448
2019 Q3	$9.95M	Sell	100,000 -95,900	-49%	-$10M	0.14%	166
2019 Q2	$21.4M	Buy	+195,900	New	+$20.8M	0.28%	116
2015 Q3	–	Sell	-3,720,000	Closed	-$458M	–	499
2015 Q2	$458M	Buy	+3,720,000	New	+$445M	5.18%	1
2015 Q1	–	Sell	-105,000	Closed	-$10.6M	–	531
2014 Q4	$10.6M	Buy	+105,000	New	+$10.2M	0.18%	199

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Alyeska Investment Group's IBB Position: Q2 2016 in Review

Alyeska Investment Group sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 570,000 shares — an estimated $49.6M sold.

Alyeska Investment Group first reported a position in IBB in Q1 2016 and held it in 1 quarter. The position peaked at $49.6M in Q1 2016. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Alyeska Investment Group reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
Alyeska Investment Group sold 570,000 iShares Biotechnology ETF shares in Q2 2016, an estimated $49.6M.
Alyeska Investment Group first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 1 quarter.
Alyeska Investment Group's iShares Biotechnology ETF position peaked at $49.6M in Q1 2016.
428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Alyeska Investment Group's 13F filing for Q2 2016, filed 15 Aug 2016.